Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. Microbe|May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialWill Stone, Almahamoudou Mahamar, Merel J Smit, et al.
BMJ Open|March 13, 2024
Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trialMarta Moreno, Aissata Barry, Markus Gmeiner, et al.
Trials|June 7, 2020
Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trialsThijs Ten Doesschate, Simone J C F M Moorlag, Thomas W van der Vaart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2021
Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia TelangiectasiaStefanie J G Veenhuis, Nienke J H van Os, Anjo J W M Janssen, et al.
Clinical & Translational Immunology|September 15, 2025
Long-term effects of influenza and Bacille Calmette-Guérin vaccination on systemic inflammationPriya A Debisarun, Rutger J Röring, Özlem Bulut, et al.
Kidney International|October 12, 2024
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International ForumDavid Kavanagh, Gianluigi Ardissino, Vicky Brocklebank, et al.
Targeted Oncology|June 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab GovitecanDirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B)Joanneke K Overbeek, Niels A D Guchelaar, Ma Ida Mohmaed Ali, et al.
Clinical Pharmacokinetics|January 12, 2026
Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost EffectivenessYang Wang, Laura H Bukkems, Rob Ter Heine, et al.
British Journal of Clinical Pharmacology|August 10, 2021
Hyperhydration with cisplatin does not influence pemetrexed exposureNikki de Rouw, Hieronymus J Derijks, Luuk B Hilbrands, et al.
Pageof 16